Putnam Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-23,338
| Closed | -$427K | – | 1154 |
|
|
2022
Q4 | $427K | Sell |
23,338
-13
| -0.1% | -$238 | ﹤0.01% | 969 |
|
|
2022
Q3 | $458K | Sell |
23,351
-423
| -2% | -$8.3K | ﹤0.01% | 951 |
|
|
2022
Q2 | $444K | Sell |
23,774
-1,915
| -7% | -$35.8K | ﹤0.01% | 966 |
|
|
2022
Q1 | $564K | Sell |
25,689
-1,921
| -7% | -$42.2K | ﹤0.01% | 969 |
|
|
2021
Q4 | $785K | Buy |
+27,610
| New | +$785K | ﹤0.01% | 890 |
|